Cargando…
May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Lung cancer (LC) is the leading cause of cancer death in the United States. Erythropoietin-producing hepatocellular receptors (EPHs) comprise the largest receptor tyrosine kinases (RTKs) family in mammals. EPHs along with their ligands, EPH-family receptor-interacting proteins (ephrins), have been f...
Autores principales: | Psilopatis, Iason, Karniadakis, Ioannis, Danos, Konstantinos Stylianos, Vrettou, Kleio, Michaelidou, Kleita, Mavridis, Konstantinos, Agelaki, Sofia, Theocharis, Stamatios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820524/ https://www.ncbi.nlm.nih.gov/pubmed/36613532 http://dx.doi.org/10.3390/ijms24010093 |
Ejemplares similares
-
The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management
por: Psilopatis, Iason, et al.
Publicado: (2022) -
EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy
por: Psilopatis, Iason, et al.
Publicado: (2022) -
The Role of Patient-Derived Organoids in Triple-Negative Breast Cancer Drug Screening
por: Psilopatis, Iason, et al.
Publicado: (2023) -
The Role of MicroRNAs in Uterine Leiomyosarcoma Diagnosis and Treatment
por: Psilopatis, Iason, et al.
Publicado: (2023) -
The Role of Peroxisome Proliferator-Activated Receptors in Endometrial Cancer
por: Psilopatis, Iason, et al.
Publicado: (2023)